Ignite Creation Date:
2024-05-06 @ 3:05 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02206295
Status:
COMPLETED
Last Update Posted:
2014-08-01
First Post:
2014-07-30
Brief Title:
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Sponsor:
Actelion
Organization:
Actelion
Organization Data
Organization:
Actelion
Class:
INDUSTRY
Study ID:
AC-065-108
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Actelion
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None